1st Quarter - Report

GREENWICH BIOSCIENCES, INC. for GREENWICH BIOSCIENCES, INC.

Firm
Client
Income
—
Expenses
$160,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

The STATES Act (S. 3032/H.R. 6043) - Issues related to the FDA; Regulation of cannabis based medicines; Regulations to implement 2018 Farm Bill Provisions

LobbyistCovered position, as disclosed
ALICE P. MEAD —
DEBORAH LYNN WALTER —

Contacted: Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); SENATE

Bills named: S. 3032 (116th), H.R. 6043 (116th)

Budget/Appropriations BUD

2019 Consolidated Appropriations Act (H.R. 648 - Sections 536 & 537's impact on other agencies; FY2020 Omnibus Appropriations Bill - Provisions related to patient safety, product regulations, and FDA enforcement

LobbyistCovered position, as disclosed
ALICE P. MEAD —
DEBORAH LYNN WALTER —

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); Agriculture, Dept of (USDA); SENATE

Bills named: H.R. 648 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.